Align's $37.5M U.K. VAT liability, new 20% VAT charges and pending appeal add fresh earnings uncertainty amid currency and mix pressures.

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Align Technology (ALGN) disclosed late Tuesday that the Jinan Intermediate People's Court in China i

Clear aligner volumes hit record levels amid $37.5 million UK VAT liability.

Dental technology company Align Technology (NASDAQ:ALGN) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 4.3% year on year to $1.06 billion. On the other hand, next quarter’s revenue guidance of $1.01 billion was less impressive, coming in 1.3% below analysts’ estimates. Its non-GAAP profit of $2.64 per share was 1.7% above analysts’ consensus estimates.

What the latest guidance and Q2 results tell you about Align Technology Align Technology (ALGN) just paired record second quarter revenue with updated 2026 guidance, giving you fresh data on how its clear aligner business, margins, and cash returns to shareholders are evolving. The company reported second quarter 2026 sales of US$1.06b, with clear aligner volumes supporting that performance while systems and services saw softer demand. Net income for the quarter was US$108.29m, and diluted...

Align Technology shares rise after Q2 earnings and revenues beat estimates, fueled by record Clear Aligner shipments and wider non-GAAP margins.

ALGN highlights record clear aligner volumes, digital workflow expansion and margin gains while balancing scanner pricing pressures and long-term growth plans.

Moby summary of Align Technology, Inc.'s Q2 2026 earnings call

Align Technology Inc (ALGN) posts record Q2 2026 revenue of $1.06 billion, driven by strong Clear Aligner volume growth, while navigating a sluggish North American retail market and a UK VAT ruling.

Align Technology (NASDAQ:ALGN) reported record second-quarter revenue of $1.06 billion, up 4.3% from a year earlier, as record clear aligner volumes and higher revenue in that business offset continued weakness in its systems and services segment. Chief Executive Officer Joe Hogan said second-quart

While the top- and bottom-line numbers for Align Technology (ALGN) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Align Technology (ALGN) delivered earnings and revenue surprises of +3.13% and +0.43%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

July 29 (Reuters) - Align Technology said on Wednesday it will add three new independent directors to its board and launch a review of its operations, following talks with activist investor Elliott

Align Technology will add three new independent directors to its board and launch a review of its operations ‌following talks with activist investor Elliott Investment Management, the company said ‌on Wednesday. The three new board ​members, who have not yet been named, will be chosen for their expertise in healthcare technology, medical devices, global operations, and scaling high-growth businesses. Elliott, one of Wall Street's most prominent activist investors, has increasingly turned its attention to ‌healthcare companies over the past ⁠year, often pushing for board representation and strategic reviews to boost performance.

Dental technology company Align Technology (NASDAQ:ALGN) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 4.3% year on year to $1.06 billion. On the other hand, next quarter’s revenue guidance of $1.01 billion was less impressive, coming in 1.3% below analysts’ estimates. Its non-GAAP profit of $2.64 per share was 1.7% above analysts’ consensus estimates.

Dental technology company Align Technology (NASDAQ:ALGN) will be announcing earnings results this Wednesday after the bell. Here’s what to look for.

ALGN's global expansion and iTero innovations support growth, but can they offset currency headwinds and macro pressures?

ALGN reports Q2 results on July 29, with investors watching Clear Aligner growth as higher volumes and digital offerings shape quarterly performance.

While the market frets about near-term headwinds, the consulting giant is quietly deploying billions to buy its next wave of growth.

Cheniere Energy (NYSE:LNG) has appointed Britt Vitalone, a veteran finance leader with experience at McKesson and Align Technology, to its Board of Directors. Vitalone will serve on both the Audit and Compensation Committees, adding expertise in corporate finance, capital allocation, and governance. The company has also adjusted several revolving credit facilities, including higher commitments, extended maturities, and updated terms for subsidiary credit lines. These governance and credit...

Myriad Genetics expands its testing portfolio and advances its Cancer Care Continuum strategy. Can reimbursement risks and cost pressures temper growth?

ALGN vs. SAUHY: Which Stock Is the Better Value Option?